Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001415889-25-011792·Tvardi Therapeutics, Inc.
Schedule 13G ownership disclosure
CARA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 140755208
Event date: 2025-04-15
- Filing-level shares
- 652,398.00
- Percent of class
- 7.0%
- David J. Tweardy
Shares: 652,398.00 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-011792
- Form type
- SCHEDULE 13G
- Filer
- Tvardi Therapeutics, Inc.
- CIK
- CIK 1346830
- Filed
- May 02, 2025
- Reporting period
- Apr 15, 2025
- Description
- Schedule 13G beneficial ownership